Literature DB >> 11893022

Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 2. Quantitative neuroanatomical assessment and analysis of the relationships between axonal tracts, residual tissue, and locomotor recovery.

Mital Joshi1, Michael G Fehlings.   

Abstract

A detailed examination of the histopathological features of the clip compression injury in mice was performed to understand the relationships between neurological function and existing pathology of the spinal cord. Adult, female CD1 mice underwent three grades of extradural clip compression injury (3-g, 8-g, and 24-g FEJOTA mouse clips), transection, and sham injury at T3-4. Quantitative behavioural assessments were performed for 4 weeks following SCI. After 4 weeks, Fluoro-Gold was introduced caudal to the SCI site, at T9, and was retrogradely transported for 5 days to the origin of spared axons through the injury site. Counts of retrogradely labeled neurons in the brain-stem, midbrain, and sensory-motor cortex indicated that the number of intact descending axons that traversed the lesion decreased with increasing injury severity (F > 28; df = 4; p < 0.0001; one-way ANOVA). Independent linear correlation analyses were performed between indices of neurological recovery (BBB and IP test), counts of retrogradely labeled neurons and morphometric assessments of normal residual tissue at the injury epicenter. The BBB test correlated strongly with the amount of residual tissue at the injury epicenter (R = 0.945, df = 28, p < 0.0001). Counts of neurons retrogradely labeled with Fluoro-Gold were also strongly correlated with the BBB scores. The extrapyramidal (raphespinal, reticulospinal, vestibulospinal, and rubrospinal) tracts had Pearson correlation coefficients (R) of 0.814, 0.812, 0.813, and 0.747, respectively (df = 28, p < 0.0001). The pyramidal (corticospinal) tract had a correlation of R = 0.747, df = 28, p < 0.0001 with the BBB scores. The IP scores also correlated strongly with the persistence of extrapyramidal (raphespinal, reticulospinal, vestibulospinal and rubrospinal) tracts with correlation coefficients of 0.801, 0.782, 0.790, and 0.836, respectively (df = 28, p < 0.0001). These data indicate that the counts of retrogradely labeled neurons at the origin of distinct descending motor pathways are predictors of the variance of the functional recovery measured by the BBB and IP tests following spinal cord injury. In addition, we provide a detailed neuroanatomical study of clip compression injury in mice that can be used to study the molecular mechanisms of SCI in knockout and transgenic mice.

Entities:  

Mesh:

Year:  2002        PMID: 11893022     DOI: 10.1089/08977150252806956

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  37 in total

1.  Genetic targeting of protease activated receptor 2 reduces inflammatory astrogliosis and improves recovery of function after spinal cord injury.

Authors:  Maja Radulovic; Hyesook Yoon; Jianmin Wu; Karim Mustafa; Michael G Fehlings; Isobel A Scarisbrick
Journal:  Neurobiol Dis       Date:  2015-08-24       Impact factor: 5.996

2.  Anti-CD11d integrin antibody treatment restores normal serotonergic projections to the dorsal, intermediate, and ventral horns of the injured spinal cord.

Authors:  Mark A Oatway; Yuhua Chen; Jamie C Bruce; Gregory A Dekaban; Lynne C Weaver
Journal:  J Neurosci       Date:  2005-01-19       Impact factor: 6.167

3.  Kallikrein cascades in traumatic spinal cord injury: in vitro evidence for roles in axonopathy and neuron degeneration.

Authors:  Maja Radulovic; Hyesook Yoon; Nadya Larson; Jianmin Wu; Rachel Linbo; Joshua E Burda; Eleftherios P Diamandis; Sachiko I Blaber; Michael Blaber; Michael G Fehlings; Isobel A Scarisbrick
Journal:  J Neuropathol Exp Neurol       Date:  2013-11       Impact factor: 3.685

4.  Self-assembling nanofibers inhibit glial scar formation and promote axon elongation after spinal cord injury.

Authors:  Vicki M Tysseling-Mattiace; Vibhu Sahni; Krista L Niece; Derin Birch; Catherine Czeisler; Michael G Fehlings; Samuel I Stupp; John A Kessler
Journal:  J Neurosci       Date:  2008-04-02       Impact factor: 6.167

5.  Longitudinal Optogenetic Motor Mapping Revealed Structural and Functional Impairments and Enhanced Corticorubral Projection after Contusive Spinal Cord Injury in Mice.

Authors:  Jun Qian; Wei Wu; Wenhui Xiong; Zhi Chai; Xiao-Ming Xu; Xiaoming Jin
Journal:  J Neurotrauma       Date:  2018-08-30       Impact factor: 5.269

6.  Transplantation of Induced Pluripotent Stem Cell-Derived Neural Stem Cells Mediate Functional Recovery Following Thoracic Spinal Cord Injury Through Remyelination of Axons.

Authors:  Ryan P Salewski; Robert A Mitchell; Lijun Li; Carl Shen; Maria Milekovskaia; Andras Nagy; Michael G Fehlings
Journal:  Stem Cells Transl Med       Date:  2015-05-15       Impact factor: 6.940

Review 7.  Alternatively activated macrophages in spinal cord injury and remission: another mechanism for repair?

Authors:  Taekyun Shin; Meejung Ahn; Changjong Moon; Seungjoon Kim; Ki-Bum Sim
Journal:  Mol Neurobiol       Date:  2013-01-16       Impact factor: 5.590

8.  Synergetic use of neural precursor cells and self-assembling peptides in experimental cervical spinal cord injury.

Authors:  Klaus Zweckberger; Yang Liu; Jian Wang; Nicole Forgione; Michael G Fehlings
Journal:  J Vis Exp       Date:  2015-02-23       Impact factor: 1.355

9.  Astrocytic YAP Promotes the Formation of Glia Scars and Neural Regeneration after Spinal Cord Injury.

Authors:  Changnan Xie; Xiya Shen; Xingxing Xu; Huitao Liu; Fayi Li; Sheng Lu; Ziran Gao; Jingjing Zhang; Qian Wu; Danlu Yang; Xiaomei Bao; Fan Zhang; Shiyang Wu; Zhaoting Lv; Minyu Zhu; Dingjun Xu; Peng Wang; Liying Cao; Wei Wang; Zengqiang Yuan; Ying Wang; Zhaoyun Li; Honglin Teng; Zhihui Huang
Journal:  J Neurosci       Date:  2020-02-17       Impact factor: 6.167

10.  Gait analysis in normal and spinal contused mice using the TreadScan system.

Authors:  Jason E Beare; Johnny R Morehouse; William H DeVries; Gaby U Enzmann; Darlene A Burke; David S K Magnuson; Scott R Whittemore
Journal:  J Neurotrauma       Date:  2009-11       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.